Announcements
- IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica
- Shareholders IMCD N.V. adopt all resolutions at AGM
- IMCD reports EBITA of EUR 127 million in the first three months of 2024
- IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
- IMCD publishes convocation for its upcoming Annual General Meeting
- IMCD Benelux expands its Beauty & Personal Care presence with the acquisition of Gova Ingredients
- IMCD further expands its food and nutrition footprint in Latin America with the acquisition of Bretano
- IMCD announces dividend proposal and Supervisory Board nominations for reappointment
- IMCD reports EBITA of EUR 515 million in 2023
- IMCD Australia and New Zealand strengthen its coatings and construction business with the acquisition of ResChem
More ▼
Key statistics
On Thursday, IMCD NV (0QVU:LSE) closed at 140.55, -16.81% below its 52-week high of 168.95, set on Mar 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 143.13 |
---|---|
High | 142.35 |
Low | 138.70 |
Bid | -- |
Offer | -- |
Previous close | 140.55 |
Average volume | 9.59k |
---|---|
Shares outstanding | 56.99m |
Free float | 55.99m |
P/E (TTM) | 27.86 |
Market cap | 8.15bn EUR |
EPS (TTM) | 5.13 EUR |
Annual div (ADY) | 2.24 EUR |
---|---|
Annual div yield (ADY) | 1.56% |
Div ex-date | May 16 2024 |
Div pay-date | May 21 2024 |
Data delayed at least 20 minutes, as of Jun 13 2024 17:36 BST.
More ▼